A Post-marketing Database Surveillance to Investigate the Risk of Hepatic Events in Hypercholesterolemic Patients Treated with ATOZET or Ezetimibe Atorvastatin coadministration in Japan (MK-0653C-853) First published 15/06/2021 Last updated 23/04/2024 EU PAS number:EUPAS41295 Study Finalised